The NHS plans to roll out Mounjaro, a weight-loss jab that can help users lose up to a quarter of their body weight, making it more potent than Ozempic. Anna Magee explains how to choose the best opti ...
The chip maker invested about $100 million in OpenAI's latest funding round, The Wall Street Journal reports. Tesla's cheapest model is no longer on sale in the U.S.
The announcement could shake up the market for such injections, since the shortage designation allowed compounding pharmacies ...
The removal of Zepbound and Mounjaro from the regulator’s shortage list could lead to restrictions on pharmacies making ...
The Food and Drug Administration declared an end to the scarcity of Eli Lilly's highly in-demand weight-loss and diabetes ...
More than 1.6 million Britons are set to get the ‘King Kong’ of fat jabs on the NHS over the next 12 years. Mounjaro – which ...
Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit ...
The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 ...
Ozempic and other diabetes-weight loss drugs have been linked to at least 162 deaths and 10,000 cases involving “serious” ...
“Its patent will expire next year, and it will be available as a generic and I will introduce it to the entire public health ...
The FDA has removed two of Eli Lilly's in-demand weight-loss and diabetes drugs from its shortage list. Diabetes drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback